138 related articles for article (PubMed ID: 25333914)
21. Extracorporeal photopheresis as an immunomodulatory agent: Haematocrit-dependent effects on natural killer cells.
Becherucci V; Allegro E; Brugnolo F; Piccini L; Gori V; Bisin S; Bindi B; Ceccantini R; Pavan P; Cunial V; Gentile F; Ermini S; Bambi F
J Clin Apher; 2017 Aug; 32(4):257-265. PubMed ID: 27476149
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of action of extracorporeal photochemotherapy.
Heshmati F
Transfus Apher Sci; 2003 Aug; 29(1):61-70. PubMed ID: 12877896
[TBL] [Abstract][Full Text] [Related]
23. Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients.
Quaglino P; Comessatti A; Ponti R; Peroni A; Mola F; Fierro MT; Savoia P; Novelli M; Bernengo MG
Int J Immunopathol Pharmacol; 2009; 22(2):353-62. PubMed ID: 19505389
[TBL] [Abstract][Full Text] [Related]
24. CFSE flow cytometric quantification of lymphocytic proliferation in extracorporeal photopheresis: use for quality control.
Evrard B; Dosgilbert A; Jacquemot N; Demeocq F; Gilles T; Chassagne J; Berger M; Tridon A
Transfus Apher Sci; 2010 Feb; 42(1):11-9. PubMed ID: 19931489
[TBL] [Abstract][Full Text] [Related]
25. Extracorporeal photophoresis augments function of CD4+CD25+FoxP3+ regulatory T cells by triggering adenosine production.
Schmitt S; Johnson TS; Karakhanova S; Näher H; Mahnke K; Enk AH
Transplantation; 2009 Aug; 88(3):411-6. PubMed ID: 19667946
[TBL] [Abstract][Full Text] [Related]
26. Extracorporeal photopheresis differentially regulates the expression of phosphorylated STAT-1 and STAT-5 in treated monocytes and T cells, respectively.
Bladon J; Taylor P
J Cutan Med Surg; 2004; 8(3):148-56. PubMed ID: 15578129
[TBL] [Abstract][Full Text] [Related]
27. Extracorporeal photochemotherapy.
Maeda A
J Dermatol Sci; 2009 Jun; 54(3):150-6. PubMed ID: 19369039
[TBL] [Abstract][Full Text] [Related]
28. [Advances of mechanism study on extracorporeal photochemotherapy to treat and prevent graft-versus-host disease in vitro--review].
Chen Z; Zhao G; Chen BA
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1376-80. PubMed ID: 21129297
[TBL] [Abstract][Full Text] [Related]
29. Extracorporeal photopheresis practice patterns: An international survey by the ASFA ECP subcommittee.
Dunbar NM; Raval JS; Johnson A; Abikoff CM; Adamski J; Cooling LL; Grossman B; Kim HC; Marques MB; Morgan S; Schmidt AE; Sloan SR; Su LL; Szczepiorkowski ZM; West FB; Wong E; Schneiderman J
J Clin Apher; 2017 Aug; 32(4):215-223. PubMed ID: 27442906
[TBL] [Abstract][Full Text] [Related]
30. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
[TBL] [Abstract][Full Text] [Related]
31. Extracorporeal photopheresis in refractory chronic graft-versus-host disease: the influence on peripheral blood T cell subpopulations. A study by the Hellenic Association of Hematology.
Tsirigotis P; Kapsimalli V; Baltadakis I; Kaloyannidis P; Karakasis D; Papalexandri A; Psarra E; Nosi E; Konsta E; Vikentiou M; Papageorgiou S; Sakellari I; Pappa V; Harhalakis N; Anagnostopoulos A; Dervenoulas J
Transfus Apher Sci; 2012 Apr; 46(2):181-8. PubMed ID: 22115608
[TBL] [Abstract][Full Text] [Related]
32. Technical comparison of four different extracorporeal photopheresis systems.
Brosig A; Hähnel V; Orsó E; Wolff D; Holler E; Ahrens N
Transfusion; 2016 Oct; 56(10):2510-2519. PubMed ID: 27456672
[TBL] [Abstract][Full Text] [Related]
33. Validation of a new automated irradiation system for off-line ECP.
Del Fante C; Klersy C; Barone E; De Vitis S; Troletti D; Mortellaro C; Musella V; Perotti C
Transfus Apher Sci; 2023 Jun; 62(3):103724. PubMed ID: 37202323
[TBL] [Abstract][Full Text] [Related]
34. Extracorporeal photopheresis: a focus on apoptosis and cytokines.
Bladon J; Taylor PC
J Dermatol Sci; 2006 Aug; 43(2):85-94. PubMed ID: 16797926
[TBL] [Abstract][Full Text] [Related]
35. Current clinical applications of extracorporeal photochemotherapy.
Capuano M; Sommese L; Pignalosa O; Parente D; Fabbricini R; Nicoletti GF; De Pascale MR; Schiano C; Napoli C
Ther Apher Dial; 2015 Apr; 19(2):103-10. PubMed ID: 25363837
[TBL] [Abstract][Full Text] [Related]
36. Apheresis buffy coat collection without photoactivation has no effect on apoptosis, cell proliferation, and total viability of mononuclear cells collected using photopheresis systems.
Szczepiorkowski ZM; Burnett CA; Dumont LJ; Abhyankar SH
Transfusion; 2018 Apr; 58(4):943-950. PubMed ID: 29451308
[TBL] [Abstract][Full Text] [Related]
37. Extracorporeal photopheresis reduces the number of mononuclear cells that produce pro-inflammatory cytokines, when tested ex-vivo.
Bladon J; Taylor P
J Clin Apher; 2002; 17(4):177-82. PubMed ID: 12494410
[TBL] [Abstract][Full Text] [Related]
38. Updating ECP action mechanisms.
Heshmati F
Transfus Apher Sci; 2014 Jun; 50(3):330-9. PubMed ID: 24837416
[TBL] [Abstract][Full Text] [Related]
39. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy.
Rubegni P; Sbano P; Cevenini G; Perari MG; Marotta G; Risulo M; Carcagnì MR; D' Ascenzo G; De Aloe G; Fimiani M
Int J Immunopathol Pharmacol; 2007; 20(4):801-7. PubMed ID: 18179753
[TBL] [Abstract][Full Text] [Related]
40. Quality control of extracorporeal photochemotherapy: Proliferation assay using CFSE validated according to ISO 15189:2007 standards.
Faivre L; Lecouflet L; Liu WQ; Khadher I; Lahaie C; Vidal M; Legouvello S; Beaumont JL; Bierling P; Rouard H; Birebent B
Cytometry B Clin Cytom; 2015 Jan; 88(1):30-9. PubMed ID: 25227323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]